A multicenter , double-blind , placebo-controlled dose-optimization study of GXR ( 1-4mg / d ) or placebo administered morning ( a.m. ) or evening ( p.m. ) adjunctive to psychostimulant was conducted in subjects ages 6-17 with suboptimal response to psychostimulant alone .